Skip to Main Content
Skip Nav Destination

Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 471–477.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal